Alunbrig – Brigatinib uses, dose and side effects
Alunbrig contains the active substance brigatinib, which belongs to a class of anticancer medicines called kinase inhibitors. Alunbrig is used to treat adults in the advanced stage of a form of lung cancer called non-small cell lung cancer. It is given to patients whose lung cancer is due to an abnormal form of a gene called anaplastic lymphoma kinase ( ALK ).
Read More